The results of the pooled analysis attest that the eosinophil count was not found to be significantly different between patients with or without severe COVID-19 (WMD, -0.01×109 ; 95% CI, -0.07 to 0.04×109; I2, 0%; p=0.99). Despite the still limited volume of data on eosinophil count in patients with COVID-19, the results of our systematic literature review and pooled analysis suggest that eosinopenia may not be associated with unfavorable progression of COVID-19.
Eosinophil count in severe coronavirus disease 2019 (COVID-19)
Lippi, Giuseppe
;
2020-01-01
Abstract
The results of the pooled analysis attest that the eosinophil count was not found to be significantly different between patients with or without severe COVID-19 (WMD, -0.01×109 ; 95% CI, -0.07 to 0.04×109; I2, 0%; p=0.99). Despite the still limited volume of data on eosinophil count in patients with COVID-19, the results of our systematic literature review and pooled analysis suggest that eosinopenia may not be associated with unfavorable progression of COVID-19.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
